Figure 2 | Scientific Reports

Figure 2

From: A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan

Figure 2The alternative text for this image may have been generated using AI.

Response to 1st-line treatment among B-NHL subtypes. CR, complete response; DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma; MCL, mantle cell lymphoma; MZL, marginal zone lymphoma; PD, progressive disease; PR, partial response; SD, stable disease. *1st-line treatment limited to R-CHOP-like/CHOP or R-COP in patients with DLBCL; R-CHOP-like/ or R-COP/COP in patients with FL; all administered treatments for other subtypes. Clinical response criteria differ for WM or CLL/SLL and these subtypes are not included in this graph. Data are tabulated and drug abbreviations explained in Table S4.

Back to article page